Table 2 Multivariate hazards of breast cancer-specific and all cause mortality at 30 years for 322 patients undergoing adjuvant radiotherapy and chemotherapy with primary operable breast cancer, stratified by oestrogen receptor status.
From: Adjuvant radiotherapy and chemotherapy in breast cancer: 30 year follow-up of survival
| Â | Â | Cancer-specific | survival | Overall | survival |
|---|---|---|---|---|---|
| Â | Patients (n = 322) | Hazard ratio (95% CI) | P-value | Hazard ratio (95% CI) | P-value |
Age (>50 years) | Â | 1.34 (0.95-1.89) | 0.097 | 1.63 (1.19-2.22) | 0.002 |
Deprivation (DEPCAT) | Â | Â | 0.226 | Â | 0.322 |
1-2 | Â | 1.00 | Â | 1.00 | Â |
3-5 | Â | 1.04 (0.68-1.60) | 0.845 | 0.94 (0.65-1.36) | 0.740 |
6-7 | Â | 1.39 (0.90-2.14) | 0.144 | 1.21 (0.82-1.77) | 0.332 |
Involved lymph nodes | Â | Â | Â | Â | Â |
1,2 or 3 | Â | 1.00 | Â | 1.00 | Â |
≥4 |  | 1.88 (1.34-2.63) | <0.001 | 1.59 (1.17-2.14) | 0.003 |
Treatment | Â | Â | 0.220 | Â | 0.309 |
Radiotherapy | Â | 1.24 (0.81-1.90) | 0.324 | 1.02 (0.70-1.48) | 0.921 |
Radiotherapy + CMF | Â | 1.00 | 1.00 | 1.00 | Â |
CMF | Â | 1.43 (0.96-2.13) | 0.082 | 1.28 (0.90-1.81) | 0.169 |